Industry
Eucatech AG
Total Trials
6
Recruiting
1
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT06832631Recruiting
VITUS Post-Market Registry
Role: collaborator
NCT06621524Active Not Recruiting
EucaLimus Post-Market Registry
Role: collaborator
NCT06678490Active Not Recruiting
Support C Post-Market Registry
Role: collaborator
NCT02496169Not ApplicableUnknown
Prospective multicEntric NonranDomized Registry
Role: lead
NCT02011984Unknown
Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system
Role: lead
NCT00825279Phase 4Completed
A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent
Role: collaborator
All 6 trials loaded